The Pituitary World News Podcast
Science
Today's podcast covers my conversation with Jill Sisco, president of the Acromegaly Community, about the recent meetings with the Food and Drug Administration (FDA), the US governmental entity responsible for approving new medications. Our conversation focuses on the original meeting held in 2021 and a recent listening session where the AC provided additional feedback to the FDA. These meetings help ensure the FDA considers patient's experiences, needs, and expectations as they provide drug development guidance to pharmaceutical companies. You can read the original report here.
Jill also briefly mentioned during our chat the "Faces of Hope" initiative they undertook a few years ago. Here's a link to that photographic essay. Worth a look!
S2E14: Steroid doses and adrenal insufficiency
S2E13: Prolactin and fertility
S2E12: Pituitary tumors and your vision
S2E11: Cushing's part 4: musings
S2E10: Podcast. Part 3: Cushing's medical management
S2E9: Recurring Cushing’s disease series: Part 2 management
S2E8: Recurring Cushing's disease series: Part 1 approaches and challenges
S2E7: DI: 2 cases
S2E6: Hyponatremia in pituitary patients
S2E5: Central Hypothyroidism
S2E4: Acromegaly (part 3), medical treatment
S2E3: Acromegaly survey results
S2E2: Aggressive Pituitary Tumors
S2E1: Growth Hormone: a candid doctor patient perspective
S1E20: Clinical presentation of pituitary disease
S1E19: Reporting from the 2015 Pituitary Disorders, Advances in Diagnosis and Management conference at UCSF
S1E18: You asked (session 2)
S1E17: Navigating growth hormone replacement
S1E16: The benefits of growth hormone replacement
S1E15: Symptoms and signs of growth hormone deficiency
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain